Trinity Biotech (TRIB) Current Leases (2015 - 2025)

Trinity Biotech (TRIB) has reported Current Leases for 11 consecutive years, with $2.6 million the latest figure, recorded in Q4 2025.

• Quarterly Current Leases rose 13.26% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (up 13.26% YoY) and the FY2025 annual result came in at $2.6 million, up 13.26% from the prior year.
• Current Leases improved to $2.6 million in Q4 2025 per TRIB's latest filing, from $2.3 million in the prior quarter.
• Over the last five years, Current Leases for TRIB reached as high as $2.6 million in Q4 2025 and fell as low as $1.7 million in Q4 2022.
• A 5-year average of $2.1 million and a median of $2.1 million in 2021 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases dropped 15.35% — and 2024, when it surged 34.89%.
• Year by year, Current Leases stood at $2.0 million in 2021, then slipped by 15.35% to $1.7 million in 2022, then grew by 1.07% to $1.7 million in 2023, then soared by 34.89% to $2.3 million in 2024, then rose by 13.26% to $2.6 million in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $2.6 million, $2.3 million, and $2.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.